Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9Y296
UPID:
TPPC4_HUMAN
Alternative names:
Hematopoietic stem/progenitor cell protein 172; Synbindin; TRS23 homolog
Alternative UPACC:
Q9Y296; A8K3A5; B4DME1
Background:
Trafficking protein particle complex subunit 4, also known as Synbindin or TRS23 homolog, is a core component of the TRAPP complexes. It acts as a guanine nucleotide exchange factor for Rab1 GTPase, facilitating vesicular transport from the endoplasmic reticulum to the Golgi and autophagy. Its potential role in dendrite postsynaptic membrane trafficking underscores its importance in cellular processes.
Therapeutic significance:
The protein is linked to a neurodevelopmental disorder characterized by epilepsy, spasticity, and brain atrophy. Understanding the role of Trafficking protein particle complex subunit 4 could open doors to potential therapeutic strategies for this debilitating condition.